Jennison Associates LLC Iovance Biotherapeutics, Inc. Transaction History

Jennison Associates LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$7.78 - $14.19 $62,667 - $114,300	8,055 Added 16.1%	58,084 $465,000
Q1 2024 May 02, 2024	SELL	$7.59 - $17.47 $312,146 - $718,471	-41,126 Reduced 45.12%	50,029 $741,000
Q4 2023 Feb 01, 2024	BUY	$3.3 - $8.89 $300,811 - $810,367	91,155 New	91,155 $741,000
Q1 2021 May 11, 2021	SELL	$28.67 - $52.59 $9.66 Million - $17.7 Million	-336,986 Closed	0 $0
Q4 2020 Feb 05, 2021	SELL	$28.04 - $50.26 $266,267 - $477,268	-9,496 Reduced 2.74%	336,986 $15.6 Million
Q3 2020 Nov 04, 2020	BUY	$27.75 - $36.3 $34,493 - $45,120	1,243 Added 0.36%	346,482 $11.4 Million
Q2 2020 Aug 06, 2020	BUY	$27.21 - $41.0 $9.39 Million - $14.2 Million	345,239 New	345,239 $9.48 Million

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.46B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.